Oncology & Cancer

Pap/HPV cotesting better for cervical cancer screening in over 30s

(HealthDay)—Liquid-based cytology (LBC) and human papillomavirus (HPV) cotesting enhances screening for cervical cancer (CxCa) and precancer among women aged 30 years and older, according to a study published online July ...

Pediatrics

American Cancer Society updates guideline for HPV vaccination

The American Cancer Society (ACS) has updated its guideline for HPV vaccination, adapting a 2019 update from the Federal Advisory Committee on Immunization Practices (ACIP). The ACS first issued a guideline for routine use ...

Oncology & Cancer

Disasters can affect cervical cancer screening for years

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011, Tohoku University scientists report in the journal PLOS ONE.

Oncology & Cancer

Prevention and prognosis of cervical cancer

Jiayao Lei's thesis addresses research questions on prevention and prognosis of cervical cancer within the framework of the interplay of human papillomavirus (HPV), vaccination, and cervical screening, and also provides insights ...

Oncology & Cancer

Cervical cancer elimination possible within two decades in the US

Scaling up cervical cancer screening coverage in the U.S. to 90% could expedite elimination of the disease and avert more than 1,000 additional cases per year, according to a new study led by researchers from Harvard T.H. ...

Oncology & Cancer

Cervical cancer screening saves lives

Cervical cancer is the third most common cancer in women worldwide, but most American women can prevent it by being screened with tests that detect human papillomaviruses (HPV).

page 1 from 18